IGC Pharma, Inc. (IGC): M&A transaction — IGC Pharma closes sale of Vancouver facility assets for ~$2.7M in non-cash consideration

IGC Pharma, Inc.

Closed Nov 13, 2025; subsidiary Holi Hemp sold equipment, inventory, and leasehold assets to Wellness Essentials Northwest LLC.
Total fair value of consideration ~$2.7M, comprising preferential manufacturing rights through Dec 2030 and 10% contingent payment if buyer sells within 5 years.
Pro forma gain on disposal of $1.05M recognized; intangible asset of $2.7M recorded for supply contract.
No cash received; deal secures manufacturing capacity at preferential pricing starting 2028.
Pro forma balance sheet shows total assets of $8.99M and stockholders' equity of $7.13M as of June 30, 2025.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

IGC Pharma, Inc. completed a disposition involving Wellness Essentials Northwest LLC for fair value of approximately $2.7 million (closed 2025-11-13).

Action: disposition
Counterparty: Wellness Essentials Northwest LLC
Consideration: fair value of approximately $2.7 million
Closing: 2025-11-13

Exact text from the filing

On November 13, 2025, the closing conditions were satisfied and the transactions under the Sale Agreement were consummated for a fair value of approximately $2.7 million.

View on SEC.gov

Browse all m&a transactions →

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-25-001713

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.